title: HIV-1 dynamics in children.
abstract: HIV-1-infected children have higher plasma viral loads and progress to disease more quickly than infected adults. To gain insight into the accelerated pathogenesis of HIV-1 in children, viral dynamics were measured following the initiation of highly active antiretroviral therapy (HAART) and compared with those reported for adults. A biphasic decline in plasma HIV-1 RNA was observed, with a rapid decrease during the first 1 to 2 weeks of therapy (phase I) followed by a slower decline (phase II). The phase I and II decay rates were not significantly different among children of different ages, pretherapy plasma HIV-1 RNA levels, or CD4 cell counts. Estimated phase I decay rates were similar to those previously reported in adults with a mean of 0.43 days(-1) and a half-life of 1.6 days. The phase II decay rates were slower in children compared with adults with a mean of 0.016 days(-1) versus 0.066 days(-1), and a half-life of 43.3 versus 14.1 days, respectively (p < .05). The mean time required to reach viral levels below detection thresholds was also longer in these children compared with that in adults. These data suggest that HIV-1 dynamics may be different in children, and that these differences may necessitate different treatment strategies.
authors.affiliation: Department of Pediatrics, University of Washington, Seattle, USA. ajmelvin@u.washington.edu
authors.forename: A J
authors.initials: AJ
authors.lastname: Melvin
authors.forename: A G
authors.initials: AG
authors.lastname: Rodrigo
authors.forename: K M
authors.initials: KM
authors.lastname: Mohan
authors.forename: P A
authors.initials: PA
authors.lastname: Lewis
authors.forename: L
authors.initials: L
authors.lastname: Manns-Arcuino
authors.forename: R W
authors.initials: RW
authors.lastname: Coombs
authors.forename: J I
authors.initials: JI
authors.lastname: Mullins
authors.forename: L M
authors.initials: LM
authors.lastname: Frenkel
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development*; D006801:Humans; D007223:Infant; D012367:RNA, Viral / Q000097:blood
chemical_list: D012367:RNA, Viral